Filing Details

Accession Number:
0000899243-21-015666
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-13 20:45:24
Reporting Period:
2021-04-12
Accepted Time:
2021-04-13 20:45:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1701541 Black Diamond Therapeutics Inc. BDTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1637054 Brent Hatzis-Schoch C/O Black Diamond Therapeutics, Inc.
One Main Street, 10Th Floor
Cambridge MA 02142
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-12 4,078 $3.20 12,478 No 4 M Direct
Common Stock Disposition 2021-04-12 4,078 $25.00 8,400 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-04-12 179,915 $0.00 4,078 $3.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
164,552 2029-06-11 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
  2. 25% of the shares subject to this option vested and became exercisable on May 22, 2020, with the remainder vesting in 36 equal monthly installments thereafter.